Skip to main content
SpringerLink
Log in

Does Reimbursement Affect Physician Decision Making?

  • Chapter
Ethical Issues in Cancer Patient Care

Part of the book series: Cancer Treatment and Research ((CTAR,volume 140))

Abstract

Cancer care is expensive, with large expenditures being associated with new technologies and Pharmaceuticals, supportive care modalities, and terminal care.1 Almost one third of an individual’s lifetime medical costs are incurred during the last several months of life. The high costs of cancer care raise important issues related to access to new cancer technologies. In particular, are all cancer patients equally likely to receive the expensive new medical developments? What is the relationship between patient’s socioeconomic status and type of health insurance and the use of cancer therapies? Do financial arrangements between physicians and insurers affect the type and intensity of cancer care? Do these factors have an effect on the type, quality, and results of care in the clinical oncology setting?

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Smith TJ. Role of granulocyte and granulocyte macrophage colony stimulating factors in clinical practice: Balancing clinical and economic concerns. American Society of Clinical Oncology Educational Book. 35th Annual Meeting. 1999: 275-299.

    Google Scholar 

  2. McIntosh H. Managed care brings major changes to cancer care. J Natl Cancer Inst 1995; 87:784–86.

    Article  PubMed  CAS  Google Scholar 

  3. Hellinger FJ. The impact of financial incentives on physician behavior in managed care plans: A review of the evidence. Med Care Res Review 1996; 53(3):294–314.

    Article  CAS  Google Scholar 

  4. Bailes JS. Health care economics of cancer in the elderly. Cancer 1997; 80:1348–50.

    Article  PubMed  CAS  Google Scholar 

  5. Ogrod ES. Compensation and quality: A physician’s view. Health Affairs 1997; 16(3):82–86.

    Article  PubMed  CAS  Google Scholar 

  6. Simon CJ and Emmons DW. Physician earnings at risk: An examination of capitated contracts. Health Affairs 1997; 16(3):120–26.

    Article  PubMed  CAS  Google Scholar 

  7. Health News Daily. 1995. Half of US physicians are associated with risk insurance plans, Nov 13, p. 4.

    Google Scholar 

  8. Miller R, Luft HS. Managed care plan performance since 1980. J Am Med Assoc 1994; 271:1512–19.

    Article  CAS  Google Scholar 

  9. Manning WF, Leibowitz A, Goldberg FA, Rogers WH, Rogers JP. A controlled trial of the effects of a prepaid group practice on use of services. N Eng J Med 1984; 310:1505–10.

    Article  CAS  Google Scholar 

  10. Clancy CM, Hillner BE. Physicians as gatekeepers: The impact of financial incentives. Arch Int Med 1989; 149:917–20.

    Article  CAS  Google Scholar 

  11. Greenfield S, Nelson EC, Zubkoff M, et al. Variations in resource utilization among medical specialties and systems of care. J Am Med Assoc 1992; 267:1624–30.

    Article  CAS  Google Scholar 

  12. Rappaport J, Gehlback S, Lemeshow S, Teres D. Resource utilization among intensive care patients: Managed care versus traditional insurance. Arch Int Med 1992; 152:2207–12.

    Article  Google Scholar 

  13. American Society of Clinical Oncology. American Society of Clinical Oncology recommendations for the use of hematopoietic colony stimulating factors: Evidence based clinical practice guidelines. J Clin Onc 1994; 12: 2471–2508.

    Google Scholar 

  14. Update of recommendations for the use of hematopoietic colony stimulating factors: Evidence-based clinical practice guidelines. J Clin On 1996; 14: 1957–1960.

    Google Scholar 

  15. Bennett CL, Smith TJ, Weeks JC et al. Use of hematopoietic colony stimulating factors: The American Society of Clinical Oncology Survey. J Clin Onc 1997; 14: 2511–2520.

    Google Scholar 

  16. Bennett CL, Somerfield M, Feinglass J, Smith TJ. Decrease in misuse/overuse of hematopoietic colony stimulating factors for solid tumors and lymphomas: Results from ASCO Surveys Related to the 1994 and 1996 ASCO CSF Guidelines. Proceedings of ASCO 1998; 17: 421a.

    Google Scholar 

  17. Park RE, Brook RH, Kosecoff J et al. Explaining variations in hospital death rates. Randomness, severity of illness, quality of care. JAMA 1990; 264: 484–490.

    Article  PubMed  CAS  Google Scholar 

  18. Bataladan P, Nelson E, Roberts J. Linking outcomes measurement to continual improvement: the serial “V” way of thinking about improving clinical care. Jt Comm J Qual Improv 1994; 20: 167–80.

    Google Scholar 

  19. Ullman M, Metzger CK, Kuzel T, Bennett CL. Performance measurement in prostate cancer: Beyond report cards. Urology 1996; 47: 356–65.

    Article  PubMed  CAS  Google Scholar 

  20. Bennett CL, Tosteson TD, Schmitt B, Weinberg PD, Ernstoff MS, Ross SD. Maximum androgen blockade with medical or surgical castration in advanced cancer: A meta-anlysis of nine published randomized controlled trials and 4128 patients using flutamide. Prostate Cancer and Prostatic Diseases 1999; 2: 4–8.

    Article  PubMed  Google Scholar 

  21. Eisenberger MA, Blumenstein BA, Crawford ED et al. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer. NEJM 1998; 339: 1036–42.

    Article  PubMed  CAS  Google Scholar 

  22. Waters TM, Bennett CL, Pajeau TS, Sobocinski KA, Klein JP, Rowlings PA, Horowitz M. The Costs and Cost-Effectiveness of Bone Marrow and Peripheral Blood Stem Cell Transplantation: What Do We Know? Bone Marrow Transplant 1998; 21:641–50.

    Article  PubMed  CAS  Google Scholar 

  23. Bennett CL, Armitage JL, Armitage GO, et al. Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: Results from the University of Nebraska 1987-1991. J Clin Oncol 1995; 13:969–973.

    PubMed  CAS  Google Scholar 

  24. Freeman MB, Vose JM, Bennett CL et al. Costs of Care for High-Dose Therapy and Autologous Transplantation for Non-Hodgkin’s Lymphoma: Results From the University of Nebraska Medical Center 1989 Through 1995; Bone Marrow Transplantation 1999; in press.

    Google Scholar 

  25. Luft HS, Bunker JP, Enthoven AC. Should operations be regionalized? The empirical relation between surgical volume and mortality. N Engl J Med 1979; 301:1364–1369.

    Article  PubMed  CAS  Google Scholar 

  26. Welch HG. Valuing clinical strategies early in their development. Annals of Int Medl 16: 263–4; 1992.

    Google Scholar 

  27. Pavletic ZS, Bishop MR, Tarantolo SR, et al. Hematopoietic recovery after allogeneic blood stem cell transplantation compared to bone marrow transplantation in patients with hematologic malignancies. J Clin Oncol 1997; 15:1608–13.

    PubMed  CAS  Google Scholar 

  28. Bennett CL, Waters TM, Stinson TJ et al. Valuing Clinical Strategies Early in Development: A Cost Analysis of Allogeneic Peripheral Blood Stem Cell Transplantation. Bone Marrow Transplantation 1999; in press.

    Google Scholar 

  29. Blaise D, Kuentz M, Fortanier C, et al. Randomized trial of lenograstim-primved blood cell versus bone marrow allogeneic transplantation: Comparison of haematological recovery and socioeconomic evaluation. Proceedings ofthe American Society of Hematology 1998; 557a.

    Google Scholar 

  30. Bennett CL, Stinson TJ, Yang T, Lurain JR. The Effect of Reimbursement Policies on the Management of Medicare Patients with Refractory Ovarian Cancer. Sem Oncol 1999; 26(1) Suppl A:34–39.

    Google Scholar 

  31. Ignoffo RJ. Medicare Reimbursement for Oral Antiemetics in Management of Chemotherapy-Induced Emesis. Am J Health-Syst Pharm 1997; 54:830–31.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Charles L. Bennett M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tammy J. Stinson M.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Robert H. Lurie Comprehensive Cancer Center, Northwestern University Medical School, Chicago, Illinois, USA

    Peter Angelos M.D., Ph.D. (Assistant Professor of Surgery, Assistant Professor of Medical Ethics and Humanities) (Assistant Professor of Surgery, Assistant Professor of Medical Ethics and Humanities)

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Bennett, C.L., Stinson, T.J. (2000). Does Reimbursement Affect Physician Decision Making?. In: Angelos, P. (eds) Ethical Issues in Cancer Patient Care. Cancer Treatment and Research, vol 140. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-3044-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-3044-9_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-3046-3

  • Online ISBN: 978-1-4757-3044-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation